14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $84.38 $96.99 Monday, 22nd Apr 2024 BPMC stock ended at $90.61. This is 4.33% more than the trading day before Friday, 19th Apr 2024. During the day the stock fluctuated 7.10% from a day low at $86.52 to a day high of $92.66.
90 days $72.25 $100.98
52 weeks $43.89 $100.98

Historical Blueprint Medicines Corporation prices

Date Open High Low Close Volume
Aug 10, 2023 $47.50 $50.32 $47.33 $49.40 757 045
Aug 09, 2023 $46.89 $48.45 $46.87 $48.00 427 882
Aug 08, 2023 $46.93 $47.79 $46.51 $46.90 752 011
Aug 07, 2023 $50.02 $50.46 $46.87 $47.14 832 615
Aug 04, 2023 $50.67 $51.24 $49.55 $49.84 593 939
Aug 03, 2023 $54.23 $54.40 $49.72 $50.88 1 893 761
Aug 02, 2023 $59.31 $60.86 $54.23 $54.30 3 157 311
Aug 01, 2023 $65.71 $65.79 $63.50 $64.14 1 190 297
Jul 31, 2023 $65.19 $68.00 $64.96 $66.00 1 500 714
Jul 28, 2023 $60.67 $64.03 $60.67 $63.12 701 181
Jul 27, 2023 $59.91 $60.70 $58.94 $59.74 578 362
Jul 26, 2023 $59.13 $60.27 $58.80 $59.10 608 375
Jul 25, 2023 $57.62 $59.35 $57.48 $58.86 893 564
Jul 24, 2023 $58.26 $58.61 $57.15 $57.81 572 606
Jul 21, 2023 $58.41 $58.74 $57.67 $58.14 870 215
Jul 20, 2023 $57.55 $58.96 $57.32 $58.40 495 285
Jul 19, 2023 $57.54 $58.43 $57.45 $57.57 511 726
Jul 18, 2023 $57.84 $58.32 $57.27 $57.28 373 107
Jul 17, 2023 $57.80 $59.03 $57.31 $57.89 368 382
Jul 14, 2023 $59.00 $59.00 $57.52 $57.61 357 350
Jul 13, 2023 $59.70 $60.18 $58.93 $59.09 366 880
Jul 12, 2023 $59.02 $59.61 $57.52 $59.58 1 140 027
Jul 11, 2023 $58.80 $58.81 $57.88 $58.25 602 472
Jul 10, 2023 $59.34 $60.46 $58.62 $59.07 577 878
Jul 07, 2023 $59.31 $60.61 $59.25 $59.80 452 419
Click to get the best stock tips daily for free!

About Blueprint Medicines Corporation

Blueprint Medicines Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advanced SM and other mast cell disorders; and Fisogatinib, an orally avail... BPMC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT